phentermine topiramate and glp 1 receptor agonists GLP-1 are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Frontiers | GLP−1 receptor agonists

Self-directed combination therapy is strongly discouraged due to safety concerns

Whether in understanding human biology or appreciating the symbolism of dark hues, "melano" reminds us of lifes complexities and beauty

Toxicology Reports, 13, 101840

2026 Jan 23;22(1):e1012013

The characteristics of glutathione are the following: (a) discovered by Hopkins in 1921 [67], (b) synthesized intracellularly by glutamate-cysteine ligase and glutathione synthetase [68], (c) exists in reduced (GSH) and oxidized (GSSG) forms, maintaining cellular redox balance [69], (d) functions in melanogenesis inhibition through tyrosinase suppression and pheomelanin synthesis [70], and (e) oral bioavailability is enhanced through liposomal formulations, S -acetyl derivatives, or co-administration with precursors [71]

Full GH therapy raises IGF-1 levels, which carries potential concerns about cell proliferation